Viking Therapeutics (VKTX) Misses Q2 EPS by 13c
Go back to Viking Therapeutics (VKTX) Misses Q2 EPS by 13c| ING Van Kampen Equity Growth Fund S 2 Class (NASDAQ: VKTX) | Delayed: 40.85 +10.74 (35.67%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $30.11 | 52 Week High | $5.17 | |||
| Open | $37.00 | 52 Week Low | $0.94 | |||
| Day High | $41.73 | P/E | N/A | |||
| Day Low | $36.34 | EPS | $0.00 | |||
| Volume | 40,861,992 | |||||
